Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

830
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
830
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

253
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
253
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

516
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
516
Survival Tree01:19

Survival Tree

245
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
245
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

408
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
408
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

405
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
405

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs.

Molecular cancer therapeutics·2026
Same author

Statistics and AI - A Fireside Conversation.

Harvard data science review·2026
Same author

Pre-transplant <i>Clostridioides difficile</i> infection predicts subsequent gastrointestinal GVHD and non-relapse mortality after allogeneic hematopoietic stem cell transplantation.

Cell transplantation·2026
Same author

Mapping the landscape and evolution of drug delivery for glioma: a bibliometric and visual analysis.

Discover oncology·2026
Same author

Traditional Chinese medicine formula Xiang Bei San suppresses the growth and metastasis of breast cancer by regulating macrophage polarization and tumor vascularization.

Journal of natural medicines·2026
Same author

Developing Predictive Models by Sharing Predictions - An Investigation of a Federated Learning Approach for ADMET Predictions.

Journal of medicinal chemistry·2026
Same journal

Inference on summaries of a model-agnostic longitudinal variable importance trajectory with application to suicide prevention.

The annals of applied statistics·2026
Same journal

A NOVEL BAYESIAN FRAMEWORK UNCOVERING BRAIN CONNECTIVITY-TO-SHAPE RELATIONSHIP IN PRECLINICAL ALZHEIMER'S DISEASE.

The annals of applied statistics·2026
Same journal

EVALUATING MULTIPLEX DIAGNOSTIC TEST USING PARTIALLY ORDERED BAYES CLASSIFIER.

The annals of applied statistics·2026
Same journal

BRIDGING THE GAP: ENHANCING THE GENERALIZABILITY OF EPIGENETIC CLOCKS THROUGH TRANSFER LEARNING.

The annals of applied statistics·2026
Same journal

TREATMENT EFFECT HETEROGENEITY AND IMPORTANCE MEASURES FOR MULTIVARIATE CONTINUOUS TREATMENTS.

The annals of applied statistics·2026
Same journal

FEDERATED LEARNING OF ROBUST INDIVIDUALIZED DECISION RULES WITH APPLICATION TO HETEROGENEOUS MULTIHOSPITAL SEPSIS POPULATION.

The annals of applied statistics·2026
See all related articles

Related Experiment Video

Updated: Nov 21, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K

BAYESIAN VARIABLE SELECTION FOR SURVIVAL DATA USING INVERSE MOMENT PRIORS.

Amir Nikooienejad1, Wenyi Wang2, Valen E Johnson1

  • 1Texas A&M University.

The Annals of Applied Statistics
|January 18, 2021
PubMed
Summary
This summary is machine-generated.

This study presents a new Bayesian method for selecting important genes in high-dimensional cancer genomic data, improving cancer type discovery and treatment prediction using censored survival data.

Keywords:
Bayesian Variable SelectionCancer GenomicsCox Proportional Hazard ModelHigh Dimensional DataNonlocal PriorSurvival Data Analysis

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K

Related Experiment Videos

Last Updated: Nov 21, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K

Area of Science:

  • Genomics
  • Biostatistics
  • Cancer Research

Background:

  • High-dimensional cancer genomic studies require efficient variable selection for gene discovery and treatment response prediction.
  • Censored survival data is commonly encountered in cancer research, posing analytical challenges.

Purpose of the Study:

  • To introduce a novel Bayesian variable selection procedure for high-dimensional genomic data with censored survival outcomes.
  • To develop and implement an R package (BVSNLP) for this procedure, enabling parallel computing and efficient model space exploration.

Main Methods:

  • A Bayesian variable selection approach utilizing a mixture prior (point mass at zero and inverse moment prior).
  • Integration with the Cox proportional hazard model's partial likelihood.
  • Implementation in the R package BVSNLP with stochastic search and Bayesian model averaging for prediction.

Main Results:

  • The proposed Bayesian algorithm demonstrated superior performance in simulation studies compared to existing variable selection methods.
  • Consistent variable selection was observed when applied to real-world cancer genomic datasets.

Conclusions:

  • The developed Bayesian procedure offers an effective tool for variable selection in cancer genomics.
  • The BVSNLP package facilitates robust gene discovery and prediction of treatment response in complex cancer datasets.